BackAimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Overview

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Common Stock

Track Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's common stock ($12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$12.49M
71.94% YoYΔ $-32.02M vs prior year quarter

Peer trimmed avg / median

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Common Stock History

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 vs. peers: Common Stock Comparison

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 (AFJKR) FAQ

The latest common stock for AFJKR is $12M as of June 2026. That compares with $45M in the prior-year period — down 71.9% year over year. Investors often review this figure alongside Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's historical trend and sector peers before judging valuation or financial health.

Over the past year, AFJKR's common stock moved from $45M to $12M — a 71.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's operating scale or balance-sheet position.

A common stock figure of $12M for AFJKR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AFJKR's common stock ($12M), review year-over-year change from $45M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.